-
Mashup Score: 18The Uromigos Episode 380: The Role of SBRT in RCC | GU Oncology Now - 19 hour(s) ago
Professor Shankar Siva of Peter MacCallum Cancer Centre joins the show to discuss the emerging role of stereotactic body radiotherapy in primary and metastatic RCC tumors.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 16
3人による2024年のGU oncoloyのレビューを切れ味鋭く解説しています。乞うご期待！
Source: spotifycreators-web.app.linkCategories: General Medicine News, Partners & KOLsTweet-
Check out the latest @uromigosjapan podcast here: https://t.co/ChzdrePhoi @YujiMiura5 @hiroshi_dko @urology_japan @JSMO_official @JCOG_official @jcaopl
-
-
Mashup Score: 16
3人による2024年のGU oncoloyのレビューを切れ味鋭く解説しています。乞うご期待！
Source: spotifycreators-web.app.linkCategories: General Medicine News, Partners & KOLsTweet-
Check out the latest @uromigosjapan podcast here: https://t.co/ChzdrePhoi @YujiMiura5 @hiroshi_dko @urology_japan @JSMO_official @JCOG_official @jcaopl
-
-
Mashup Score: 15Episode 375: Renal Cancer 2024 Highlights by The Uromigos - 11 day(s) ago
David McDermott (and his dog, Finn) join the show to review the top data from 2024 in RCC
Source: creators.spotify.comCategories: General Medicine News, Partners & KOLsTweet-
Checkout our 2024 highlight podcasts for RCC, Bladder and Prostate Cancer! https://t.co/762qXdyEz7
-
-
Mashup Score: 26
Dr. Matt Galsky joins Brian and Tom to discuss the most impactful data in bladder cancer from 2024.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet-
📅 To continue our roundup of the top GI data of 2024, Dr. @MattGalsky of @TischCancer reviews the year's biggest developments in bladder cancer in episode 376. 🔵 Listen on GU Oncology Now: https://t.co/QhRVBPwvpp 🟢 Listen on Spotify: https://t.co/rwySA7qvnG 🟣 Listen on… https://t.co/6QFbf8TGSn https://t.co/VsswkcRKG1
-
-
Mashup Score: 27
Dr. David McDermott joins the podcast to review the top data from 2024 in the renal cell carcinoma field.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet-
⭐ Join us and Dr. David McDermott of @BIDMChealth for a review of the top RCC highlights of 2024, including the recent KEYNOTE-564 results. 🔵 Listen on GU Oncology Now: https://t.co/Y5EGcPW3qd 🟢 Listen on Spotify: https://t.co/X5o3Ky8mOw 🟣 Listen on Apple Podcasts:… https://t.co/fPVvL6axc0 https://t.co/JUglntzhFf
-
-
Mashup Score: 20
Dr. Jim Brugarolas joins the podcast to discuss his talk from IKCS 2024 and the broad topic of resistance to HIF inhibitors.
Source: guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet-
👉 In our latest episode, special guest @JBrugarolas discusses his talk from IKCS 2024 on HIF resistance, and delves into the development of HIF and VEGF inhibitors. 🔵 Listen on GU Oncology Now: https://t.co/L5VQEs2PiT 🟢 Listen on Spotify: https://t.co/InV1ktNinM 🟣 Listen… https://t.co/tZ0GVEYvQm https://t.co/YFmW3BWTQj
-
-
Mashup Score: 5Episode 373: KEYNOTE-564 Asian OSとANNARの解説 by The Uromigos - 1 month(s) ago
JSCO2024で発表されたKEYNOTE-564東アジア人OSデータとANNAR biomarker studyの解説とディスカッションです
Source: spotifycreators-web.app.linkCategories: General Medicine News, Partners & KOLsTweet-
The latest Uromigos Japan episode is out! https://t.co/EQ47iNh6jl https://t.co/AdQxxMMFCy
-
-
Mashup Score: 8Episode 372: FDA Accelerated Approval Process - 1 month(s) ago
The Uromigos · Episode
Source: open.spotify.comCategories: General Medicine News, Partners & KOLsTweet-
🔊 Episode 372 is out now - we're joined by Dan Suzman, Deputy Oncology Director of the FDA, to discuss the Accelerated Approval process and its requirements, successes, and challenges. 🟢 Listen on Spotify: https://t.co/GsCXUS71QN 🟣 Listen on Apple Podcasts:… https://t.co/8G8bqehtWu https://t.co/eYRtB4H8N2
-
-
Mashup Score: 3Episode 372: FDA Accelerated Approval Process by The Uromigos - 1 month(s) ago
Dan Suzman from FDA joins us to discuss the Accelerated Approval process, requirements, successes and challenges.
Source: spotifycreators-web.app.linkCategories: General Medicine News, Partners & KOLsTweet-
Dan Suzman from #FDA joins us to discuss the Accelerated Approval process. https://t.co/sAxT5Eqx2P https://t.co/npPY3Ha2Pz
-
⭐ Professor @_ShankarSiva of @PeterMacCC joins the show to discuss the emerging role of stereotactic body radiotherapy in primary and metastatic RCC tumors. 🔵 Listen on GU Oncology Now: https://t.co/hbhXFGYZ40 🟢 Listen on Spotify: https://t.co/rXl3u1LCCs 🟣 Listen on Apple… https://t.co/1sZsTd9ymC https://t.co/y9sPwh2TVV